Eupatolide Inhibits PDGF‐induced Proliferation and Migration of Aortic Smooth Muscle Cells Through ROS‐dependent Heme Oxygenase‐1 Induction
- 8 January 2013
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 27 (11), 1700-1707
- https://doi.org/10.1002/ptr.4924
Abstract
The abnormal proliferation and migration of vascular smooth muscle cell (VSMC) contributes importantly to the pathogenesis of atherosclerosis and restenosis. Here, we investigated the effects of eupatolide (EuTL), a sesquiterpene lactone isolated from the medicinal plant Inula britannica, on platelet-derived growth factor (PDGF)-induced proliferation and migration of primary rat aortic smooth muscle cells (RASMCs), as well as its underlying mechanisms. EuTL remarkably inhibited PDGF-induced proliferation and migration of RASMCs. Treatment of RASMCs with EuTL induced both protein and mRNA expression of heme oxygenase-1 (HO-1). SB203580 (a p38 inhibitor), SP600125 (a JNK inhibitor), U0126 (a MEK inhibitor) and LY294002 (a PI3K inhibitor) did not suppress EuTL-induced HO-1 expression; however, N-acetylcysteine (NAC, an antioxidant) blocked EuTL-induced HO-1 expression. Moreover, treatment of RASMCs with EuTL increased reactive oxygen species (ROS) accumulation and nuclear translocation of nuclear factor-E2-related factor 2 (Nrf2); however, this translocation was also inhibited by NAC. NAC or inhibition of HO-1 significantly attenuated the inhibitory effects of EuTL on PDGF-induced proliferation and migration of RASMCs. Taken together, these findings suggest that EuTL could suppress PDGF-induced proliferation and migration of VSMCs through HO-1 induction via ROS-Nrf2 pathway and may be a potential HO-1 inducer for preventing or treating vascular diseases. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2010-0007366)
- Ministry of Education, Science and Technology and the Korean Health Technology R&D Project (A111311)
This publication has 32 references indexed in Scilit:
- Ethanol Extract of Prunella vulgaris var. lilacina Inhibits HMGB1 Release by Induction of Heme Oxygenase‐1 in LPS‐activated RAW 264.7 Cells and CLP‐induced Septic MicePhytotherapy Research, 2011
- PI3K and ERK/Nrf2 pathways are involved in oleanolic acid-induced heme oxygenase-1 expression in rat vascular smooth muscle cellsJournal of Cellular Biochemistry, 2011
- Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extractAtherosclerosis, 2010
- Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide FormationJournal of Biological Chemistry, 2010
- New Sesquiterpene Dimers fromInula britannicaInhibit NF-κB Activation and NO and TNF-α Production in LPS-Stimulated RAW264.7 CellsPlanta Medica, 2005
- Pathobiology of Atherosclerosis-a Brief ReviewSeminars in Thrombosis and Hemostasis, 2004
- Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genesProceedings of the National Academy of Sciences of the United States of America, 2004
- Adenovirus-Mediated Heme Oxygenase-1 Gene Transfer Inhibits the Development of Atherosclerosis in Apolipoprotein E–Deficient MiceCirculation, 2001
- Nrf2, a Cap'n'Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 GeneOnline Journal of Public Health Informatics, 1999
- Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domainGenes & Development, 1999